Concepedia

Efficacy and Safety of Anti–Interleukin 6 Receptor Monoclonal Antibody (Tocilizumab) in Colombian Patients With Takayasu Arteritis

Carlos A. Cañas, Felipe Cañas, Jorge Hernán Izquierdo, M M Ramos Mejia, Fabio Bonilla‐Abadía, Gabriel J. Tobón

JCR Journal of Clinical Rheumatology · 2014 · 53 citations · 9 references

Abstract

This study shows a clinical, biological, and radiological response in patients with refractory TA treated with TCZ.

References

9

The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis

William P. Arend, Beat A. Michel, D. Blöch et al. · Arthritis & Rheumatism · 1990 · 2.2K citations

Anti–tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis

Gary S. Hoffman, Peter A. Merkel, Richard Brasington et al. · Arthritis & Rheumatism · 2004 · 421 citations

Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up

Eamonn Molloy, Carol A. Langford, Tiffany Clark et al. · Annals of the Rheumatic Diseases · 2008 · 250 citations · Full text

Tocilizumab: a novel therapy for patients with large-vessel vasculitis

Carlo Salvarani, L. Magnani, Mariagrazia Catanoso et al. · Lara D. Veeken · 2011 · 225 citations · Full text

Successful treatment of a patient with takayasu arteritis using a humanized anti–interleukin‐6 receptor antibody

Norihiro Nishimoto, Hideko Nakahara, Naoko Yoshio‐Hoshino et al. · Arthritis & Rheumatism · 2008 · 180 citations